APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antipyretic Medicine for Elderly

Compare research editions
View pricing & licenses

Selected research

Industry Research

Antipyretic Medicine for Elderly Industry Research Report 2026

23 December 2025139 pages

Choose your research edition.

Industry ResearchAntipyretic Medicine for Elderly Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Antipyretic Medicine for Elderly Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Antipyretic Medicine for Elderly Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antipyretic Medicine for Elderly Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Antipyretic Medicine for Elderly Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Antipyretic Medicine for Elderly market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Antipyretic Medicine for Elderly is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Antipyretic Medicine for Elderly is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Antipyretic Medicine for Elderly is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Antipyretic Medicine for Elderly include Zhejiang Kangle, Xinhua Pharmaceutical, Hebei Jiheng, Changshu Huagang, Anhui Fubore, Anhui BBCA Likang, Temad, Strides Shasun and SKPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Antipyretic Medicine for Elderly market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Antipyretic Medicine for Elderly Market by Company

Zhejiang Kangle

Xinhua Pharmaceutical

Hebei Jiheng

Changshu Huagang

Anhui Fubore

Anhui BBCA Likang

Temad

Strides Shasun

SKPL

Novacyl

Mallinckrodt

IOLCP

Granules India

Granules Biocause

Farmson

Atabay

Anqiu Lu'an

Antipyretic Medicine for Elderly Segment by Type

Acetaminophen

Ibuprofen

Other

Antipyretic Medicine for Elderly Segment by Application

Online Sales

Offline Sales

Antipyretic Medicine for Elderly Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic Medicine for Elderly market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antipyretic Medicine for Elderly and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic Medicine for Elderly.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Antipyretic Medicine for Elderly manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Antipyretic Medicine for Elderly by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Antipyretic Medicine for Elderly in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antipyretic Medicine for Elderly Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Antipyretic Medicine for Elderly Sales (k units) of Manufacturers (2021-2026) Table 7. Global Antipyretic Medicine for Elderly Sales Market Share by Manufacturers (2021-2026) Table 8. Global Antipyretic Medicine for Elderly Revenue of Manufacturers (2021-2026) Table 9. Global Antipyretic Medicine for Elderly Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Antipyretic Medicine for Elderly Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Antipyretic Medicine for Elderly Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Antipyretic Medicine for Elderly, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Antipyretic Medicine for Elderly, Product Type & Application Table 14. Global Antipyretic Medicine for Elderly Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Antipyretic Medicine for Elderly by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zhejiang Kangle Company Information Table 19. Zhejiang Kangle Business Overview Table 20. Zhejiang Kangle Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Zhejiang Kangle Antipyretic Medicine for Elderly Product Portfolio Table 22. Zhejiang Kangle Recent Developments Table 23. Xinhua Pharmaceutical Company Information Table 24. Xinhua Pharmaceutical Business Overview Table 25. Xinhua Pharmaceutical Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Xinhua Pharmaceutical Antipyretic Medicine for Elderly Product Portfolio Table 27. Xinhua Pharmaceutical Recent Developments Table 28. Hebei Jiheng Company Information Table 29. Hebei Jiheng Business Overview Table 30. Hebei Jiheng Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Hebei Jiheng Antipyretic Medicine for Elderly Product Portfolio Table 32. Hebei Jiheng Recent Developments Table 33. Changshu Huagang Company Information Table 34. Changshu Huagang Business Overview Table 35. Changshu Huagang Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Changshu Huagang Antipyretic Medicine for Elderly Product Portfolio Table 37. Changshu Huagang Recent Developments Table 38. Anhui Fubore Company Information Table 39. Anhui Fubore Business Overview Table 40. Anhui Fubore Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Anhui Fubore Antipyretic Medicine for Elderly Product Portfolio Table 42. Anhui Fubore Recent Developments Table 43. Anhui BBCA Likang Company Information Table 44. Anhui BBCA Likang Business Overview Table 45. Anhui BBCA Likang Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Anhui BBCA Likang Antipyretic Medicine for Elderly Product Portfolio Table 47. Anhui BBCA Likang Recent Developments Table 48. Temad Company Information Table 49. Temad Business Overview Table 50. Temad Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Temad Antipyretic Medicine for Elderly Product Portfolio Table 52. Temad Recent Developments Table 53. Strides Shasun Company Information Table 54. Strides Shasun Business Overview Table 55. Strides Shasun Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. Strides Shasun Antipyretic Medicine for Elderly Product Portfolio Table 57. Strides Shasun Recent Developments Table 58. SKPL Company Information Table 59. SKPL Business Overview Table 60. SKPL Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. SKPL Antipyretic Medicine for Elderly Product Portfolio Table 62. SKPL Recent Developments Table 63. Novacyl Company Information Table 64. Novacyl Business Overview Table 65. Novacyl Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Novacyl Antipyretic Medicine for Elderly Product Portfolio Table 67. Novacyl Recent Developments Table 68. Mallinckrodt Company Information Table 69. Mallinckrodt Business Overview Table 70. Mallinckrodt Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Mallinckrodt Antipyretic Medicine for Elderly Product Portfolio Table 72. Mallinckrodt Recent Developments Table 73. IOLCP Company Information Table 74. IOLCP Business Overview Table 75. IOLCP Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. IOLCP Antipyretic Medicine for Elderly Product Portfolio Table 77. IOLCP Recent Developments Table 78. Granules India Company Information Table 79. Granules India Business Overview Table 80. Granules India Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Granules India Antipyretic Medicine for Elderly Product Portfolio Table 82. Granules India Recent Developments Table 83. Granules Biocause Company Information Table 84. Granules Biocause Business Overview Table 85. Granules Biocause Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Granules Biocause Antipyretic Medicine for Elderly Product Portfolio Table 87. Granules Biocause Recent Developments Table 88. Farmson Company Information Table 89. Farmson Business Overview Table 90. Farmson Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Farmson Antipyretic Medicine for Elderly Product Portfolio Table 92. Farmson Recent Developments Table 93. Atabay Company Information Table 94. Atabay Business Overview Table 95. Atabay Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Atabay Antipyretic Medicine for Elderly Product Portfolio Table 97. Atabay Recent Developments Table 98. Anqiu Lu'an Company Information Table 99. Anqiu Lu'an Business Overview Table 100. Anqiu Lu'an Antipyretic Medicine for Elderly Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Anqiu Lu'an Antipyretic Medicine for Elderly Product Portfolio Table 102. Anqiu Lu'an Recent Developments Table 103. Global Antipyretic Medicine for Elderly Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 104. Global Antipyretic Medicine for Elderly Sales by Region (2021-2026) & (k units) Table 105. Global Antipyretic Medicine for Elderly Sales Market Share by Region (2021-2026) Table 106. Global Antipyretic Medicine for Elderly Sales by Region (2027-2032) & (k units) Table 107. Global Antipyretic Medicine for Elderly Sales Market Share by Region (2027-2032) Table 108. Global Antipyretic Medicine for Elderly Revenue by Region (2021-2026) & (US$ Million) Table 109. Global Antipyretic Medicine for Elderly Revenue Market Share by Region (2021-2026) Table 110. Global Antipyretic Medicine for Elderly Revenue by Region (2027-2032) & (US$ Million) Table 111. Global Antipyretic Medicine for Elderly Revenue Market Share by Region (2027-2032) Table 112. North America Antipyretic Medicine for Elderly Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. North America Antipyretic Medicine for Elderly Sales by Country (2021-2026) & (k units) Table 114. North America Antipyretic Medicine for Elderly Sales by Country (2027-2032) & (k units) Table 115. North America Antipyretic Medicine for Elderly Revenue by Country (2021-2026) & (US$ Million) Table 116. North America Antipyretic Medicine for Elderly Revenue by Country (2027-2032) & (US$ Million) Table 117. Europe Antipyretic Medicine for Elderly Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Europe Antipyretic Medicine for Elderly Sales by Country (2021-2026) & (k units) Table 119. Europe Antipyretic Medicine for Elderly Sales by Country (2027-2032) & (k units) Table 120. Europe Antipyretic Medicine for Elderly Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Antipyretic Medicine for Elderly Revenue by Country (2027-2032) & (US$ Million) Table 122. Asia Pacific Antipyretic Medicine for Elderly Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Asia Pacific Antipyretic Medicine for Elderly Sales by Country (2021-2026) & (k units) Table 124. Asia Pacific Antipyretic Medicine for Elderly Sales by Country (2027-2032) & (k units) Table 125. Asia Pacific Antipyretic Medicine for Elderly Revenue by Country (2021-2026) & (US$ Million) Table 126. Asia Pacific Antipyretic Medicine for Elderly Revenue by Country (2027-2032) & (US$ Million) Table 127. South America Antipyretic Medicine for Elderly Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. South America Antipyretic Medicine for Elderly Sales by Country (2021-2026) & (k units) Table 129. South America Antipyretic Medicine for Elderly Sales by Country (2027-2032) & (k units) Table 130. South America Antipyretic Medicine for Elderly Revenue by Country (2021-2026) & (US$ Million) Table 131. South America Antipyretic Medicine for Elderly Revenue by Country (2027-2032) & (US$ Million) Table 132. Middle East and Africa Antipyretic Medicine for Elderly Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Middle East and Africa Antipyretic Medicine for Elderly Sales by Country (2021-2026) & (k units) Table 134. Middle East and Africa Antipyretic Medicine for Elderly Sales by Country (2027-2032) & (k units) Table 135. Middle East and Africa Antipyretic Medicine for Elderly Revenue by Country (2021-2026) & (US$ Million) Table 136. Middle East and Africa Antipyretic Medicine for Elderly Revenue by Country (2027-2032) & (US$ Million) Table 137. Global Antipyretic Medicine for Elderly Sales by Type (2021-2026) & (k units) Table 138. Global Antipyretic Medicine for Elderly Sales by Type (2027-2032) & (k units) Table 139. Global Antipyretic Medicine for Elderly Sales Market Share by Type (2021-2026) Table 140. Global Antipyretic Medicine for Elderly Sales Market Share by Type (2027-2032) Table 141. Global Antipyretic Medicine for Elderly Revenue by Type (2021-2026) & (US$ Million) Table 142. Global Antipyretic Medicine for Elderly Revenue by Type (2027-2032) & (US$ Million) Table 143. Global Antipyretic Medicine for Elderly Revenue Market Share by Type (2021-2026) Table 144. Global Antipyretic Medicine for Elderly Revenue Market Share by Type (2027-2032) Table 145. Global Antipyretic Medicine for Elderly Price by Type (2021-2026) & (USD/unit) Table 146. Global Antipyretic Medicine for Elderly Price by Type (2027-2032) & (USD/unit) Table 147. Global Antipyretic Medicine for Elderly Sales by Application (2021-2026) & (k units) Table 148. Global Antipyretic Medicine for Elderly Sales by Application (2027-2032) & (k units) Table 149. Global Antipyretic Medicine for Elderly Sales Market Share by Application (2021-2026) Table 150. Global Antipyretic Medicine for Elderly Sales Market Share by Application (2027-2032) Table 151. Global Antipyretic Medicine for Elderly Revenue by Application (2021-2026) & (US$ Million) Table 152. Global Antipyretic Medicine for Elderly Revenue by Application (2027-2032) & (US$ Million) Table 153. Global Antipyretic Medicine for Elderly Revenue Market Share by Application (2021-2026) Table 154. Global Antipyretic Medicine for Elderly Revenue Market Share by Application (2027-2032) Table 155. Global Antipyretic Medicine for Elderly Price by Application (2021-2026) & (USD/unit) Table 156. Global Antipyretic Medicine for Elderly Price by Application (2027-2032) & (USD/unit) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Antipyretic Medicine for Elderly Distributors List Table 160. Antipyretic Medicine for Elderly Customers List Table 161. Antipyretic Medicine for Elderly Industry Trends Table 162. Antipyretic Medicine for Elderly Industry Drivers Table 163. Antipyretic Medicine for Elderly Industry Restraints Table 164. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Antipyretic Medicine for Elderly Product Image Figure 5. Global Antipyretic Medicine for Elderly Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Antipyretic Medicine for Elderly Market Size (2021-2032) & (US$ Million) Figure 7. Global Antipyretic Medicine for Elderly Sales (2021-2032) & (k units) Figure 8. Global Antipyretic Medicine for Elderly Average Price (USD/unit) & (2021-2032) Figure 9. Acetaminophen Product Image Figure 10. Ibuprofen Product Image Figure 11. Other Product Image Figure 12. Online Sales Product Image Figure 13. Offline Sales Product Image Figure 14. Global Antipyretic Medicine for Elderly Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Antipyretic Medicine for Elderly, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Antipyretic Medicine for Elderly Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Antipyretic Medicine for Elderly Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Antipyretic Medicine for Elderly Sales by Region in 2025 Figure 20. Global Antipyretic Medicine for Elderly Revenue by Region in 2025 Figure 21. North America Antipyretic Medicine for Elderly Market Size by Country in 2025 Figure 22. North America Antipyretic Medicine for Elderly Sales Market Share by Country (2021-2032) Figure 23. North America Antipyretic Medicine for Elderly Revenue Market Share by Country (2021-2032) Figure 24. United States Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Antipyretic Medicine for Elderly Market Size by Country in 2025 Figure 28. Europe Antipyretic Medicine for Elderly Sales Market Share by Country (2021-2032) Figure 29. Europe Antipyretic Medicine for Elderly Revenue Market Share by Country (2021-2032) Figure 30. Germany Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Antipyretic Medicine for Elderly Market Size by Country in 2025 Figure 41. Asia Pacific Antipyretic Medicine for Elderly Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Antipyretic Medicine for Elderly Revenue Market Share by Country (2021-2032) Figure 43. China Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Antipyretic Medicine for Elderly Market Size by Country in 2025 Figure 52. South America Antipyretic Medicine for Elderly Sales Market Share by Country (2021-2032) Figure 53. South America Antipyretic Medicine for Elderly Revenue Market Share by Country (2021-2032) Figure 54. Brazil Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Antipyretic Medicine for Elderly Market Size by Country in 2025 Figure 58. Middle East and Africa Antipyretic Medicine for Elderly Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Antipyretic Medicine for Elderly Revenue Market Share by Country (2021-2032) Figure 60. Egypt Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Antipyretic Medicine for Elderly Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Antipyretic Medicine for Elderly Sales Market Share by Type (2021-2032) Figure 66. Global Antipyretic Medicine for Elderly Revenue Market Share by Type (2021-2032) Figure 67. Global Antipyretic Medicine for Elderly Price (USD/unit) by Type (2021-2032) Figure 68. Global Antipyretic Medicine for Elderly Sales Market Share by Application (2021-2032) Figure 69. Global Antipyretic Medicine for Elderly Revenue Market Share by Application (2021-2032) Figure 70. Global Antipyretic Medicine for Elderly Price (USD/unit) by Application (2021-2032) Figure 71. Antipyretic Medicine for Elderly Value Chain Figure 72. Antipyretic Medicine for Elderly Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Antipyretic Medicine for Elderly Industry Opportunities and Challenges

Scope & coverage.

Types
  • Acetaminophen
  • Ibuprofen
  • Other
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Zhejiang Kangle
  • Xinhua Pharmaceutical
  • Hebei Jiheng
  • Changshu Huagang
  • Anhui Fubore
  • Anhui BBCA Likang
  • Temad
  • Strides Shasun
  • SKPL
  • Novacyl
  • Mallinckrodt
  • IOLCP
  • Granules India
  • Granules Biocause
  • Farmson
  • Atabay
  • Anqiu Lu'an

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Antipyretic Medicine for Elderly Market Size (2021-2032)
  4. 2.2.2 Global Antipyretic Medicine for Elderly Sales (2021-2032)
  5. 2.2.3 Global Antipyretic Medicine for Elderly Market Average Price (2021-2032)
  6. 2.3 Antipyretic Medicine for Elderly by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Acetaminophen
  9. 2.3.3 Ibuprofen
  10. 2.3.4 Other
  11. 2.4 Antipyretic Medicine for Elderly by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Online Sales
  14. 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Antipyretic Medicine for Elderly Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Antipyretic Medicine for Elderly Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Antipyretic Medicine for Elderly Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Antipyretic Medicine for Elderly Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Antipyretic Medicine for Elderly Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Antipyretic Medicine for Elderly, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Antipyretic Medicine for Elderly, Product Type & Application
  8. 3.8 Global Manufacturers of Antipyretic Medicine for Elderly, Established Date
  9. 3.9 Global Antipyretic Medicine for Elderly Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhejiang Kangle
  2. 4.1.1 Zhejiang Kangle Company Information
  3. 4.1.2 Zhejiang Kangle Business Overview
  4. 4.1.3 Zhejiang Kangle Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zhejiang Kangle Antipyretic Medicine for Elderly Product Portfolio
  6. 4.1.5 Zhejiang Kangle Recent Developments
  7. 4.2 Xinhua Pharmaceutical
  8. 4.2.1 Xinhua Pharmaceutical Company Information
  9. 4.2.2 Xinhua Pharmaceutical Business Overview
  10. 4.2.3 Xinhua Pharmaceutical Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Xinhua Pharmaceutical Antipyretic Medicine for Elderly Product Portfolio
  12. 4.2.5 Xinhua Pharmaceutical Recent Developments
  13. 4.3 Hebei Jiheng
  14. 4.3.1 Hebei Jiheng Company Information
  15. 4.3.2 Hebei Jiheng Business Overview
  16. 4.3.3 Hebei Jiheng Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Hebei Jiheng Antipyretic Medicine for Elderly Product Portfolio
  18. 4.3.5 Hebei Jiheng Recent Developments
  19. 4.4 Changshu Huagang
  20. 4.4.1 Changshu Huagang Company Information
  21. 4.4.2 Changshu Huagang Business Overview
  22. 4.4.3 Changshu Huagang Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Changshu Huagang Antipyretic Medicine for Elderly Product Portfolio
  24. 4.4.5 Changshu Huagang Recent Developments
  25. 4.5 Anhui Fubore
  26. 4.5.1 Anhui Fubore Company Information
  27. 4.5.2 Anhui Fubore Business Overview
  28. 4.5.3 Anhui Fubore Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Anhui Fubore Antipyretic Medicine for Elderly Product Portfolio
  30. 4.5.5 Anhui Fubore Recent Developments
  31. 4.6 Anhui BBCA Likang
  32. 4.6.1 Anhui BBCA Likang Company Information
  33. 4.6.2 Anhui BBCA Likang Business Overview
  34. 4.6.3 Anhui BBCA Likang Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Anhui BBCA Likang Antipyretic Medicine for Elderly Product Portfolio
  36. 4.6.5 Anhui BBCA Likang Recent Developments
  37. 4.7 Temad
  38. 4.7.1 Temad Company Information
  39. 4.7.2 Temad Business Overview
  40. 4.7.3 Temad Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Temad Antipyretic Medicine for Elderly Product Portfolio
  42. 4.7.5 Temad Recent Developments
  43. 4.8 Strides Shasun
  44. 4.8.1 Strides Shasun Company Information
  45. 4.8.2 Strides Shasun Business Overview
  46. 4.8.3 Strides Shasun Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Strides Shasun Antipyretic Medicine for Elderly Product Portfolio
  48. 4.8.5 Strides Shasun Recent Developments
  49. 4.9 SKPL
  50. 4.9.1 SKPL Company Information
  51. 4.9.2 SKPL Business Overview
  52. 4.9.3 SKPL Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 SKPL Antipyretic Medicine for Elderly Product Portfolio
  54. 4.9.5 SKPL Recent Developments
  55. 4.10 Novacyl
  56. 4.10.1 Novacyl Company Information
  57. 4.10.2 Novacyl Business Overview
  58. 4.10.3 Novacyl Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Novacyl Antipyretic Medicine for Elderly Product Portfolio
  60. 4.10.5 Novacyl Recent Developments
  61. 4.11 Mallinckrodt
  62. 4.11.1 Mallinckrodt Company Information
  63. 4.11.2 Mallinckrodt Business Overview
  64. 4.11.3 Mallinckrodt Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Mallinckrodt Antipyretic Medicine for Elderly Product Portfolio
  66. 4.11.5 Mallinckrodt Recent Developments
  67. 4.12 IOLCP
  68. 4.12.1 IOLCP Company Information
  69. 4.12.2 IOLCP Business Overview
  70. 4.12.3 IOLCP Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 IOLCP Antipyretic Medicine for Elderly Product Portfolio
  72. 4.12.5 IOLCP Recent Developments
  73. 4.13 Granules India
  74. 4.13.1 Granules India Company Information
  75. 4.13.2 Granules India Business Overview
  76. 4.13.3 Granules India Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Granules India Antipyretic Medicine for Elderly Product Portfolio
  78. 4.13.5 Granules India Recent Developments
  79. 4.14 Granules Biocause
  80. 4.14.1 Granules Biocause Company Information
  81. 4.14.2 Granules Biocause Business Overview
  82. 4.14.3 Granules Biocause Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Granules Biocause Antipyretic Medicine for Elderly Product Portfolio
  84. 4.14.5 Granules Biocause Recent Developments
  85. 4.15 Farmson
  86. 4.15.1 Farmson Company Information
  87. 4.15.2 Farmson Business Overview
  88. 4.15.3 Farmson Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Farmson Antipyretic Medicine for Elderly Product Portfolio
  90. 4.15.5 Farmson Recent Developments
  91. 4.16 Atabay
  92. 4.16.1 Atabay Company Information
  93. 4.16.2 Atabay Business Overview
  94. 4.16.3 Atabay Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Atabay Antipyretic Medicine for Elderly Product Portfolio
  96. 4.16.5 Atabay Recent Developments
  97. 4.17 Anqiu Lu'an
  98. 4.17.1 Anqiu Lu'an Company Information
  99. 4.17.2 Anqiu Lu'an Business Overview
  100. 4.17.3 Anqiu Lu'an Antipyretic Medicine for Elderly Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Anqiu Lu'an Antipyretic Medicine for Elderly Product Portfolio
  102. 4.17.5 Anqiu Lu'an Recent Developments
5 Global Antipyretic Medicine for Elderly Market Scenario by Region
  1. 5.1 Global Antipyretic Medicine for Elderly Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Antipyretic Medicine for Elderly Sales by Region: 2021-2032
  3. 5.2.1 Global Antipyretic Medicine for Elderly Sales by Region: 2021-2026
  4. 5.2.2 Global Antipyretic Medicine for Elderly Sales by Region: 2027-2032
  5. 5.3 Global Antipyretic Medicine for Elderly Revenue by Region: 2021-2032
  6. 5.3.1 Global Antipyretic Medicine for Elderly Revenue by Region: 2021-2026
  7. 5.3.2 Global Antipyretic Medicine for Elderly Revenue by Region: 2027-2032
  8. 5.4 North America Antipyretic Medicine for Elderly Market Facts & Figures by Country
  9. 5.4.1 North America Antipyretic Medicine for Elderly Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Antipyretic Medicine for Elderly Sales by Country (2021-2032)
  11. 5.4.3 North America Antipyretic Medicine for Elderly Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Antipyretic Medicine for Elderly Market Facts & Figures by Country
  16. 5.5.1 Europe Antipyretic Medicine for Elderly Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Antipyretic Medicine for Elderly Sales by Country (2021-2032)
  18. 5.5.3 Europe Antipyretic Medicine for Elderly Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Antipyretic Medicine for Elderly Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Antipyretic Medicine for Elderly Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Antipyretic Medicine for Elderly Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Antipyretic Medicine for Elderly Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Antipyretic Medicine for Elderly Market Facts & Figures by Country
  41. 5.7.1 South America Antipyretic Medicine for Elderly Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Antipyretic Medicine for Elderly Sales by Country (2021-2032)
  43. 5.7.3 South America Antipyretic Medicine for Elderly Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Antipyretic Medicine for Elderly Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Antipyretic Medicine for Elderly Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Antipyretic Medicine for Elderly Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Antipyretic Medicine for Elderly Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Antipyretic Medicine for Elderly Sales by Type (2021-2032)
  2. 6.1.1 Global Antipyretic Medicine for Elderly Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Antipyretic Medicine for Elderly Sales Market Share by Type (2021-2032)
  4. 6.2 Global Antipyretic Medicine for Elderly Revenue by Type (2021-2032)
  5. 6.2.1 Global Antipyretic Medicine for Elderly Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Antipyretic Medicine for Elderly Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Antipyretic Medicine for Elderly Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Antipyretic Medicine for Elderly Sales by Application (2021-2032)
  2. 7.1.1 Global Antipyretic Medicine for Elderly Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Antipyretic Medicine for Elderly Sales Market Share by Application (2021-2032)
  4. 7.2 Global Antipyretic Medicine for Elderly Revenue by Application (2021-2032)
  5. 7.2.1 Global Antipyretic Medicine for Elderly Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Antipyretic Medicine for Elderly Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Antipyretic Medicine for Elderly Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Antipyretic Medicine for Elderly Value Chain Analysis
  2. 8.1.1 Antipyretic Medicine for Elderly Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Antipyretic Medicine for Elderly Production Mode & Process
  5. 8.2 Antipyretic Medicine for Elderly Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Antipyretic Medicine for Elderly Distributors
  8. 8.2.3 Antipyretic Medicine for Elderly Customers
9 Global Antipyretic Medicine for Elderly Analyzing Market Dynamics
  1. 9.1 Antipyretic Medicine for Elderly Industry Trends
  2. 9.2 Antipyretic Medicine for Elderly Industry Drivers
  3. 9.3 Antipyretic Medicine for Elderly Industry Opportunities and Challenges
  4. 9.4 Antipyretic Medicine for Elderly Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst